Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Secukinumab for Plaque Psoriasis
Recruiting1 awardPhase 3
San Antonio, Texas
This trial was a study of a new medication for plaque psoriasis in children aged 6-18 years old. The study compared the new medication to a placebo and an active control (a different medication).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.